Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Ionis Pharmaceuticals's Zilganersen Sodium?
Zilganersen Sodium is an antisense oligonucleotide commercialized by Ionis Pharmaceuticals, with a leading Phase III program in Alexander Disease. According...